|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM304989169 |
| 003 |
DE-627 |
| 005 |
20250226122215.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2019.108331
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1016.xml
|
| 035 |
|
|
|a (DE-627)NLM304989169
|
| 035 |
|
|
|a (NLM)31899330
|
| 035 |
|
|
|a (PII)S1521-6616(19)30577-7
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Nam, Ki Heon
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Predictive value of mesangial C3 and C4d deposition in IgA nephropathy
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 04.08.2020
|
| 500 |
|
|
|a Date Revised 04.08.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a ErratumIn: Clin Immunol. 2020 Apr;213:108386. doi: 10.1016/j.clim.2020.108386. - PMID 32209314
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2020 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a We aimed to determine the relative contribution of each complement (C3 and C4d) deposition to the progression of IgA nephropathy (IgAN). We enrolled a total of 380 patients with biopsy-confirmed IgAN. Mesangial deposition of C3(<2+ vs. ≥2+) and C4d(positive vs. negative) was evaluated by immunofluorescence staining and immunohistochemistry, respectively. Study endpoint was the composite of a 30% decline in eGFR or ESRD. The risk of reaching the primary outcome was significantly higher in patients having C3 ≥ 2+ and C4d(+) than in corresponding counterparts. Adding C3 deposition to clinical data acquired at kidney biopsy modestly increased the area under the receiver-operating characteristic curve, net reclassification improvement, and integrated discrimination improvement (IDI); adding C4d increased IDI only. In conclusion, mesangial C3 and C4d deposition was an independent risk factor for progression of IgAN. C3 showed better predictability than C4d, suggesting that lectin pathway alone has limited clinical prognostic value
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a C3
|
| 650 |
|
4 |
|a C4d
|
| 650 |
|
4 |
|a Complement
|
| 650 |
|
4 |
|a IgA nephropathy
|
| 650 |
|
7 |
|a C3 protein, human
|2 NLM
|
| 650 |
|
7 |
|a Complement C3
|2 NLM
|
| 650 |
|
7 |
|a Complement C4
|2 NLM
|
| 700 |
1 |
|
|a Joo, Young Su
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lee, Changhyun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lee, Sangmi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kim, Joohwan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yun, Hae-Ryong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Park, Jung Tak
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chang, Tae Ik
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ryu, Dong-Ryeol
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yoo, Tae-Hyun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chin, Ho Jun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kang, Shin-Wook
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jeong, Hyeon Joo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lim, Beom Jin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Han, Seung Hyeok
|e verfasserin
|4 aut
|
| 700 |
0 |
|
|a Korean GlomeruloNEphritis sTudy (KoGNET) Group
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 211(2020) vom: 25. Feb., Seite 108331
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
| 773 |
1 |
8 |
|g volume:211
|g year:2020
|g day:25
|g month:02
|g pages:108331
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2019.108331
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 211
|j 2020
|b 25
|c 02
|h 108331
|